World COVID-19: Syria receives its first vaccines from COVAX
Novavax COVID-19 vaccine in Australia: When will we get it? And how does it work?
Australia is expecting to get 51 million doses of Novavax this year, but when exactly might they arrive? And how well is the vaccine performing in clinical trials? Firstly, how does Novavax work?SARS-CoV-2, the virus which causes COVID-19 disease, has spike proteins.Pfizer, AstraZeneca and Novavax vaccines all work by training the immune system to recognise and fight these spike proteins, but they each use different technologies to do this.Unlike the , the Novavax vaccine contains exactly the same spike protein as the virus.
Syria has received its first vaccines against coronavirus as part of the COVAX initiative for the distribution of vaccines around the world. 203,000 doses delivered this Thursday in the province of Damascus and nearly 54,000 the day before in the northwestern Syria. The vaccination campaign will be able to start.
officially, just over 50,000 people have contracted the coronavirus in Syria. But health actors know these underestimated figures.
Got a COVID vaccine question? Ask our medical experts in the ABC coronavirus blog
To bring you up to speed, here's a rundown of common COVID vaccines and where they fit into Australia's vaccination rollout.Associate professor Hassan Vally from La Trobe University and the ABC's national medical reporter Sophie Scott will be answering questions in the COVID blog from 11:00am AEST.
Hakan Bilgin is the President of Physicians of the World Turkey, an NGO present in Idleb and Afrin, in northwestern Syria: "We see in our centers more and more cases related to COVID," he explains . Many more people with pneumonia symptoms, respiratory problems. So we notice that there are very important warning signs at the medical level on Idleb and Afrin. Médecins du Monde decided to strengthen its on-site screening capabilities.
► to read also:
The 53,800 doses received Wednesday for this part of the country are little, but it is a start, greeting Yasser Najeib, Director of the Technical Committee of the Syrian Immunization Group. This NGO consortium conducts immunization programs in the Syrian Northwest since 2017. It was he who has received Covax vaccines and who will lead this campaign in the 93 structures he created over the years.
COVID-19: The COVAX Initiative for Funding for more
Vaccines © Chandan Khanna AFP Pfizer vaccine doses against COVID-19. (Illustration Image) To help the poorest countries access coronavirus vaccines, the COVAX program needs money. He has just launched a campaign to collect $ 2 billion, in order to reserve additional doses. This is a supported initiative by Washington. The United States has indeed co-organized the donor event on Thursday, April 15th. A day that concluded by the collection of $ 400 million, or 20% of the money sought.
"In each vaccination center we have refrigerators to store vaccines. We will use these refrigerators to also store vaccines against CVIV-19, says Yasser Najeib. But we have appointed new nurses who will receive specific training.
Health personnel should be the first beneficiaries of these vaccines. The rhythm of the vaccination campaign will then depend on the upcoming deliveries of.
and in the Idleb region where the fighting continues and where rebel groups still control whole sections of the territory the arrival of vaccines arouses hope for the population.
► to read also:
India Is a Warning .
The world’s largest vaccine producer is struggling to overcome its latest COVID-19 surge—and that’s everyone’s problem.What is taking place in India isn’t so much a wave as it is a wall: Charts showing the country’s infection rate and death toll, which has also reached record numbers in the country, depict curves that have shot up into vertical lines. Public-health experts aren’t optimistic that they will slope down anytime soon.